![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-desktop-headergif-63893.gif)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-mobile-headergif-78265.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.businesswire.com/news/home/20200917005081/en/Apnimed-Successfully-Completes-Phase-1-Study-in-Lead-Program-for-Obstructive-Sleep-Apnea
https://www.fiercebiotech.com/biotech/dermavant-hires-cso-from-glaxosmithkline-buys-excessive-sweating-drug
https://www.pharmacompass.com/pdf/news/accords-oxybutynin-chloride-approved-in-us-for-overactive-bladder-1457002012.pdf
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=111850&utm_source=twitter&utm_medium=twitterfeed&utm_campaign=pharminews#.VRp1MPyUdqV